BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the...
Q2 2026
Aug 3, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Oct 28, 2025
